ResMed (RMD) Revenue — Quarter Ended Dec 31, 2025
Revenue increased in the current quarter compared to the prior quarter. The reported revenue also rose relative to the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2025 · FY2026 Q2
Revenue increased in the current quarter compared to the prior quarter. The reported revenue also rose relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.4B
Revenue reported for this quarter.
Quarter-over-quarter
+6.5%
Change from the immediately preceding quarter.
Year-over-year
+11.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $1.3B | +7.9% |
| Jun 30, 2025 | $1.3B | +10.2% |
| Sep 30, 2025 | $1.3B | +9.1% |
| Dec 31, 2025 | $1.4B | +11.0% |
Revenue performance
The reported revenue for the quarter was higher than the immediately preceding quarter. This marks a continuation of the upward trend observed over recent quarters.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher. The sequential growth from the prior quarter was also positive.
What to watch
The filing context does not provide specific causes for the revenue changes; monitor future filings for any shifts in operating trends.